rethinkPeptides Search
Menu
Study breakdown

Opioid Peptides Selectively Relax Airway Muscles by Blocking Non-Cholinergic Nerve Signals

In VitroPreliminary evidence
The takeaway

Opioid peptides selectively inhibit the non-cholinergic nerve-driven contraction of airway muscle via prejunctional receptors, with dynorphin being the most potent natural peptide.

Selective for non-cholinergic contraction

Opioid peptides blocked the substance P-driven airway constriction while leaving cholinergic contraction largely intact

What the researchers found

Opioid peptides selectively inhibit non-cholinergic excitatory neurotransmission in airways via prejunctional receptors, with dynorphin being the most potent endogenous peptide.

Why it matters

Non-cholinergic nerve signaling contributes to airway constriction in asthma. If opioid peptides naturally regulate this pathway, they could be relevant to understanding and treating asthma.

How the study worked

Guinea pig bronchial strip chains were electrically stimulated. Responses to opioid peptides and direct muscle stimulants (acetylcholine, substance P) were compared.

What this study cannot tell us

In-vitro study in guinea pig airways. Human airway opioid pharmacology may differ. Only electrical stimulation was used, not natural nerve reflexes.

How to read the evidence

Preliminary in-vitro study in guinea pig airways. Provides a clear pharmacological profile but direct human airway relevance needs validation.

When this study was published

Published in 1990. The role of opioid receptors in airway regulation has been further studied, with clinical relevance to respiratory depression from opioid medications.

The bigger picture

Non-cholinergic nerve signaling contributes to airway constriction in conditions like asthma. The finding that opioid peptides naturally regulate this pathway suggests the endogenous opioid system may help protect against excessive airway narrowing. This could explain why stress and mood affect breathing.

Questions still open

  • Could opioid-based therapies target airway constriction in asthma?
  • Is the airway opioid system impaired in severe asthma patients?

Common questions

How could opioids help with airway problems?
By blocking the non-cholinergic nerve signals that cause airway constriction, opioid peptides could potentially reduce bronchospasm. However, systemic opioids carry too many risks — a targeted airway approach would be needed.
Why is the selectivity important?
The airways have multiple types of nerve signaling. Opioids specifically target the non-cholinergic pathway (linked to inflammation-driven constriction in asthma) while leaving normal cholinergic airway control mostly intact.

Read the original research

Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.

The Journal of pharmacy and pharmacology, 42(3), 214-6

Citation

Kamikawa, Y; Shimo, Y. (1990). Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.. The Journal of pharmacy and pharmacology, 42(3), 214-6.